Cargando…
Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
BACKGROUND: Niemann–Pick disease type C (NPC) is a rare, progressive, neurodegenerative disease associated with neurovisceral manifestations resulting from lysosomal dysfunction and aberrant lipid accumulation. A multicentre, prospective observational study (Clinical Trials.gov ID: NCT02435030) of i...
Autores principales: | Mengel, Eugen, Bembi, Bruno, del Toro, Mireia, Deodato, Federica, Gautschi, Matthias, Grunewald, Stephanie, Grønborg, Sabine, Héron, Bénédicte, Maier, Esther M., Roubertie, Agathe, Santra, Saikat, Tylki-Szymanska, Anna, Day, Simon, Symonds, Tara, Hudgens, Stacie, Patterson, Marc C., Guldberg, Christina, Ingemann, Linda, Petersen, Nikolaj H. T., Kirkegaard, Thomas, í Dali, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684888/ https://www.ncbi.nlm.nih.gov/pubmed/33228797 http://dx.doi.org/10.1186/s13023-020-01616-0 |
Ejemplares similares
-
Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
por: Mengel, Eugen, et al.
Publicado: (2021) -
Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment
por: Mengel, Eugen, et al.
Publicado: (2021) -
Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale
por: Patterson, Marc C., et al.
Publicado: (2021) -
Treatment trials in Niemann-Pick type C disease
por: Sitarska, Dominika, et al.
Publicado: (2021) -
Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective
por: Mengel, Eugen, et al.
Publicado: (2021)